Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
K-RAS and EGFR in Lung Cancer
ClinicalTrials.gov study NCT03951233. IPD Sharing: Not stated. Countries: 1. Publications: 43.
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
ClinicalTrials.gov study NCT04085315. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of TY-9591 in Advanced Non-small Cell Lung Cancer(NSCLC) Patients With EGFR Positive Mutation
ClinicalTrials.gov study NCT04204473. IPD Sharing: NO. Countries: 1. Publications: 0.
Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant Nsclc
ClinicalTrials.gov study NCT01955421. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gefitinib for EGFR Sensitive Mutation Postoperative Stage Ib NSCLC Patients
ClinicalTrials.gov study NCT02526537. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Study of AZD9291 in NSCLC Patients Harboring T790M Mutation Who Failed EGFR TKI and With Brain and/or LMS
ClinicalTrials.gov study NCT03257124. IPD Sharing: NO. Countries: 1. Publications: 13.
A Study of Toripalimab+ Pemetrexed Plus Carboplatin in Patients With EGFR-mutation Positive and T790M Negative After Progression on EGFR-TKI Treatment
ClinicalTrials.gov study NCT03513666. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast Cancer
ClinicalTrials.gov study NCT02833766. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC
ClinicalTrials.gov study NCT03736837. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study to Evaluate JAK Inhibitor Cream in EGFR-inhibitor-induced Skin Rash
ClinicalTrials.gov study NCT05120362. IPD Sharing: NO. Countries: 1. Publications: 1.
Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05104281. IPD Sharing: YES. Countries: 1. Publications: 1.
Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma
ClinicalTrials.gov study NCT02621333. IPD Sharing: NO. Countries: 1. Publications: 4.
Neoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy
ClinicalTrials.gov study NCT05469022. IPD Sharing: Not stated. Countries: 1. Publications: 14.
Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04425681. IPD Sharing: NO. Countries: 1. Publications: 14.
Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data
ClinicalTrials.gov study NCT07287904. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations
ClinicalTrials.gov study NCT04790409. IPD Sharing: NO. Countries: 1. Publications: 1.
Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC
ClinicalTrials.gov study NCT06554613. IPD Sharing: NO. Countries: 0. Publications: 2.
Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or m
ClinicalTrials.gov study NCT00997230. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR
ClinicalTrials.gov study NCT02581436. IPD Sharing: NO. Countries: 1. Publications: 6.
Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC
ClinicalTrials.gov study NCT06376084. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.